肺癌手術市場規模、佔有率和成長分析（按設備類型、類型、最終用戶和地區分類）—產業預測（2026-2033 年）

預計到 2024 年，肺癌手術市場價值將達到 61.2 億美元，到 2025 年將成長至 63.7 億美元，到 2033 年將成長至 87.9 億美元，在預測期（2026-2033 年）內複合年成長率為 4.1%。

肺癌手術市場是醫療保健領域至關重要且充滿活力的行業，其發展主要受全球肺癌高發病率和高死亡率的驅動。包括微創手術（如胸腔鏡輔助手術 (VATS) 和機器人輔助手術）在內的創新手術技術正被日益廣泛地採用，以減輕患者疼痛并加快康復速度，從而改善患者預後。推動市場成長的因素包括肺癌發生率的上升、早期檢測意識的增強以及手術技術的進步。儘管持續的研究正在推動手術效果的改善和新技術的探索，但高成本和先進手術的普及程度有限等挑戰仍然存在。總體而言，主要行業參與者之間的合作正在推動手術實踐的改進，確保更多患者獲得有效的治療，並在肺癌治療過程中擁有更高的生活品質。

肺癌手術市場促進因素

肺癌，尤其是開發中國家日益嚴重的菸草危機，已成為全球男性和女性的主要死因之一。肺癌病例和死亡人數的驚人成長構成了一項重大的全球健康挑戰。肺癌不僅對患者本身造成影響，也對其家庭造成沉重打擊，凸顯了其嚴重的公共衛生問題。肺癌被定義為由肺組織細胞不受控制增殖引起的惡性腫瘤，其發病率的不斷上升凸顯了採取有效手術干預和綜合治療策略以對抗這種毀滅性疾病的緊迫性。

肺癌手術市場的限制

肺癌手術市場面臨諸多挑戰，可能阻礙其成長。其中一個主要限制因素是手術費用高昂，這可能會限制許多患者的就醫機會。此外，一些國家也面臨技術限制，進一步阻礙了市場發展。國際認證和資質審核流程漫長，也可能減緩該領域的進展。此外，醫療技術領域的激烈競爭也增加了市場的複雜性，因為企業難以在眾多產品中脫穎而出，從而影響了市場的整體擴張潛力。

肺癌手術市場趨勢

肺癌手術市場正呈現顯著的研發成長趨勢，旨在改善患者預後並提高手術精準度。臨床試驗數量激增，凸顯了標靶治療和免疫療法等創新治療方法作為傳統手術治療方法之外的極具前景的替代方案。此外，微創手術技術的進步正在改變產業格局，使患者能夠更快康復並享受更高的生活品質。隨著相關人員尋求整合最尖端科技並改進現有流程，這種創新驅動力預計將推動市場成長，最終革新肺癌治療。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 生態系測繪
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術評估
• 監管環境
• 疾病流行病學
• 專利分析

全球肺癌手術市場規模（按器材類型和複合年成長率分類）（2026-2033 年）

• 手術器械
  • 電動手術器械
  • 手動儀器
  • 訂書機
  • 鉗子
  • 牽開器
  • 肋骨剪刀
  • 刀具
  • 夾鉗
  • 剪刀
  • 套管針
  • 電梯
  • 其他
• 監控和視覺化系統
  • 攝影機和影像支援系統
  • 具有光學可視化的內視鏡套管
• 內視鏡手術設備

全球肺癌手術市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 開胸手術
  • 切除術
  • 袖狀切除術
  • 切除術
  • 肺切除術
• 微創手術

全球肺癌手術市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

• 醫院
• 門診手術中心

全球肺癌手術市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Ethicon Llc.（Johnson & Johnson Group）
• Medtronic Plc.
• Olympus Corporation
• Intuitive Surgical Inc.
• Siemens Healthineers
• Teleflex Incorporated
• Accuray Incorporated
• Angiodynamics Inc.
• Key Surgical Llc.
• KLS Martin Group
• Ackermann Instrumente Gmbh
• Karl Storz Gmbh
• Scanlan International, Inc.
• Trokamed Gmbh
• Surgical Holdings
• Fusionkraft Surgical Instruments
• Richard Wolf Gmbh
• Sontec Instruments Inc.
• Wexler Surgical Inc.
• Phoenix Surgical Instruments Ltd.（Steris Ims）

結論與建議

Lung Cancer Surgery Market size was valued at USD 6.12 Billion in 2024 and is poised to grow from USD 6.37 Billion in 2025 to USD 8.79 Billion by 2033, growing at a CAGR of 4.1% during the forecast period (2026-2033).

The Lung Cancer Surgery market is a vital and dynamic sector within healthcare, driven by the high prevalence and mortality associated with lung cancer globally. Innovative surgical techniques, such as minimally invasive approaches including video-assisted thoracic surgery (VATS) and robotic-assisted procedures, are increasingly adopted, enhancing patient outcomes through reduced pain and quicker recovery times. Factors propelling market growth include the rising incidence of lung cancer, heightened awareness surrounding early detection, and advancements in surgical technologies. Ongoing research aims to refine surgical outcomes and explore novel methods, while challenges like high costs and limited access to sophisticated procedures persist. Overall, collaboration among major industry players aims to improve surgical practices, ensuring more patients receive effective interventions and a better quality of life in lung cancer treatment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Lung Cancer Surgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Lung Cancer Surgery Market Segments Analysis

Global Lung Cancer Surgery Market is segmented by Device Type, Type, End-User and Region. Based on Device Type, the market is segmented into Surgical instruments, Monitoring & Visualizing Systems, Endosurgical Equipment. Based on Type, the market is segmented into Thoracotomy, Minimally Invasive Surgeries. Based on End-User, the market is segmented into Hospitals, Ambulatory Surgery Centres. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Lung Cancer Surgery Market

Lung cancer stands as the leading cause of death for both men and women across the globe, driven largely by the escalating tobacco crisis prevalent in developing nations. This alarming rise in lung cancer cases and fatalities poses a substantial health challenge worldwide. The repercussions of lung cancer are profound, affecting not only the patients but also their families, highlighting its status as a critical public health concern. Defined as a malignant growth resulting from the uncontrolled growth of lung tissue cells, lung cancer's increasing incidence underscores the urgent need for effective surgical interventions and comprehensive treatment strategies to combat this devastating disease.

Restraints in the Lung Cancer Surgery Market

The lung cancer surgery market faces several challenges that may hinder its growth. One significant constraint is the high expense associated with the surgical procedures, which can restrict access for many patients. Additionally, certain countries encounter technical limitations that further impede market development. The lengthy process required for international certifications and qualifications can also slow down advancements in the field. Moreover, fierce competition within the medical technology sector adds another layer of complexity, as companies strive to stand out amidst a myriad of options, ultimately affecting the market's overall expansion potential.

Market Trends of the Lung Cancer Surgery Market

The lung cancer surgery market is experiencing a significant trend towards increasing research and development efforts aimed at enhancing patient outcomes and surgical precision. A surge in clinical trials is being observed, focusing on innovative treatment modalities such as targeted therapies and immunotherapies, which offer promising alternatives to traditional surgical options. Additionally, advancements in minimally invasive surgical techniques are revolutionizing the landscape, providing patients with reduced recovery times and improved quality of life. This commitment to innovation is expected to drive market growth, as stakeholders seek to integrate cutting-edge technologies and refine existing procedures, ultimately transforming lung cancer care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Disease Epidemiology
• Patent Analysis

Global Lung Cancer Surgery Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Surgical instruments
  • Powdered Surgical Instruments
  • Hand Instruments
  • Staplers
  • Forceps
  • Retractors
  • Rib Shears
  • Cutters
  • Clamps
  • Scissors
  • Trocars
  • Elevators
  • Others
• Monitoring & Visualizing Systems
  • Cameras and Video Support
  • Endoscopic Trocars with Optical Views
• Endosurgical Equipment

Global Lung Cancer Surgery Market Size by Type & CAGR (2026-2033)

• Market Overview
• Thoracotomy
  • Lobectomy
  • Sleeve Resection
  • Segmentectomy
  • Pneumonectomy
• Minimally Invasive Surgeries

Global Lung Cancer Surgery Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgery Centres

Global Lung Cancer Surgery Market Size & CAGR (2026-2033)

• North America (Device Type, Type, End-User)
  • US
  • Canada
• Europe (Device Type, Type, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Device Type, Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Device Type, Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Ethicon Llc. (Johnson & Johnson Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Angiodynamics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Key Surgical Llc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLS Martin Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ackermann Instrumente Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karl Storz Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scanlan International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trokamed Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgical Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fusionkraft Surgical Instruments
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richard Wolf Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sontec Instruments Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wexler Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phoenix Surgical Instruments Ltd. (Steris Ims)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation